Talon Therapeutics Overview
- Year Founded
-
2002
- Status
-
Acquired/Merged
- Employees
-
24
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$44.1M
- Investors
-
1
Talon Therapeutics General Information
Description
Operator of a biopharmaceutical company. The company is involved in research and development of products in cancer therapeutics market.
Contact Information
Corporate Office
- 400 Oyster Point Boulevard
- Suite 200
- South San Francisco, CA 94080
- United States
Corporate Office
- 400 Oyster Point Boulevard
- Suite 200
- South San Francisco, CA 94080
- United States
Talon Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 18-Jun-2013 | $44.1M | Completed | Clinical Trials - Phase 3 | ||
| 3. PIPE | 09-Jan-2012 | Completed | Generating Revenue | |||
| 2. PIPE | 07-Jun-2010 | $40M | $52.4M | Completed | Generating Revenue | |
| 1. PIPE | 08-Aug-2009 | $12.4M | $12.4M | Completed | Generating Revenue |
Talon Therapeutics Patents
Talon Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2009223158-A1 | Formulations of vitamin k analogs for topical use | Active | 13-Mar-2008 | ||
| AU-2009223158-B2 | Formulations of vitamin k analogs for topical use | Inactive | 13-Mar-2008 | ||
| CA-2718262-A1 | Formulations of vitamin k analogs for topical use | Inactive | 13-Mar-2008 | ||
| EP-2265255-A1 | Formulations of vitamin k analogs for topical use | Inactive | 13-Mar-2008 | ||
| JP-2015042658-A | Formulations of vitamin k analogs for topical use | Pending | 13-Mar-2008 | A61K47/14 |
Talon Therapeutics Signals
Talon Therapeutics Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Deerfield Management | Venture Capital | Minority | ||
| OrbiMed | Growth/Expansion | Minority | ||
| Perceptive Advisors | Venture Capital | Minority | ||
| Warburg Pincus | PE/Buyout | Minority |
Talon Therapeutics FAQs
-
When was Talon Therapeutics founded?
Talon Therapeutics was founded in 2002.
-
Where is Talon Therapeutics headquartered?
Talon Therapeutics is headquartered in South San Francisco, CA.
-
What is the size of Talon Therapeutics?
Talon Therapeutics has 24 total employees.
-
What industry is Talon Therapeutics in?
Talon Therapeutics’s primary industry is Pharmaceuticals.
-
Is Talon Therapeutics a private or public company?
Talon Therapeutics is a Private company.
-
What is the current valuation of Talon Therapeutics?
The current valuation of Talon Therapeutics is .
-
What is Talon Therapeutics’s current revenue?
The current revenue for Talon Therapeutics is .
-
How much funding has Talon Therapeutics raised over time?
Talon Therapeutics has raised $63.4M.
-
Who are Talon Therapeutics’s investors?
Deerfield Management, OrbiMed, Perceptive Advisors, and Warburg Pincus have invested in Talon Therapeutics.
-
When was Talon Therapeutics acquired?
Talon Therapeutics was acquired on 18-Jun-2013.
-
Who acquired Talon Therapeutics?
Talon Therapeutics was acquired by Spectrum Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process